Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

SHE:301281 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	445.75	457.46	445.94	442.31	419.67	365.95
Other Revenue	8.69	6.26	1.64	0.55	1.22	1.11
Revenue	454.44	463.72	447.58	442.87	420.89	367.06
Revenue Growth (YoY)	-1.26%	3.60%	1.06%	5.22%	14.67%	18.02%
Cost of Revenue	231.31	266.76	240.86	264.82	246.14	187.25
Gross Profit	223.13	196.96	206.73	178.04	174.75	179.81
Selling, General & Admin	130.53	116.12	99.72	56.03	63.1	71.71
Research & Development	39.09	35.82	43.86	26.97	24.43	27.84
Other Operating Expenses	13.2	4.19	4.36	5.3	4.47	5.33
Operating Expenses	184.39	156.42	148.25	89.14	92.11	103.96
Operating Income	38.74	40.54	58.48	88.91	82.64	75.85
Interest Expense	-0.05	-0.04	-	-	-	-1.83
Interest & Investment Income	11.86	15.4	15.97	1.33	0.96	0.11
Currency Exchange Gain (Loss)	-0.05	-0.59	1.15	1.55	-1.11	-0.55
Other Non Operating Income (Expenses)	-0.77	-2.03	0.09	-0.32	0.05	-0.38
EBT Excluding Unusual Items	49.73	53.29	75.7	91.47	82.55	73.2
Gain (Loss) on Sale of Investments	0.48	0.8	0.54	-	-	-
Gain (Loss) on Sale of Assets	-0.39	-0.84	0.04	0.37	-0.04	-0.09
Legal Settlements	-0.14	-0.14	-	-	-	-
Other Unusual Items	19.06	12.61	3.45	6.47	7.41	7.97
Pretax Income	68.74	65.71	79.74	98.3	89.92	81.08
Income Tax Expense	1.85	5.44	2.7	7.02	11.75	12.43
Net Income	66.86	60.27	77.04	91.28	78.17	68.65
Net Income to Common	66.86	60.27	77.04	91.28	78.17	68.65
Net Income Growth	7.97%	-21.77%	-15.60%	16.77%	13.87%	127.73%
Shares Outstanding (Basic)	108	108	101	81	81	81
Shares Outstanding (Diluted)	108	108	101	81	81	81
Shares Change (YoY)	-0.47%	6.18%	24.38%	0.53%	-0.47%	0.34%
EPS (Basic)	0.62	0.56	0.76	1.12	0.96	0.84
EPS (Diluted)	0.62	0.56	0.76	1.12	0.96	0.84
EPS Growth	8.48%	-26.32%	-32.14%	16.15%	14.40%	126.95%
Free Cash Flow	-276.78	-356.9	-33.12	84.75	31.83	98.04
Free Cash Flow Per Share	-2.57	-3.32	-0.33	1.04	0.39	1.20
Dividend Per Share	0.200	0.200	0.300	0.286	-	-
Dividend Growth	-33.33%	-33.33%	5.00%	-	-	-
Gross Margin	49.10%	42.47%	46.19%	40.20%	41.52%	48.99%
Operating Margin	8.53%	8.74%	13.06%	20.08%	19.63%	20.66%
Profit Margin	14.71%	13.00%	17.21%	20.61%	18.57%	18.70%
Free Cash Flow Margin	-60.91%	-76.96%	-7.40%	19.14%	7.56%	26.71%
EBITDA	83.39	83.84	107.43	122.54	109.5	101.2
EBITDA Margin	18.35%	18.08%	24.00%	27.67%	26.02%	27.57%
D&A For EBITDA	44.65	43.3	48.95	33.63	26.86	25.35
EBIT	38.74	40.54	58.48	88.91	82.64	75.85
EBIT Margin	8.53%	8.74%	13.06%	20.08%	19.63%	20.66%
Effective Tax Rate	2.69%	8.27%	3.38%	7.14%	13.06%	15.33%
Revenue as Reported	454.44	463.72	447.58	442.87	420.89	367.06
Advertising Expenses	-	4.03	1.89	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.